• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Compound CAS No. 1217778-64-7: (R)-tert-Butyl Piperidin-3-ylmethylcarbamate Hydrochloride

Compound CAS No. 1217778-64-7, also known as (R)-tert-butyl piperidin-3-ylmethylcarbamate hydrochloride, is a highly specialized chemical entity with significant potential in the fields of pharmacology and organic synthesis. This compound has garnered attention due to its unique structural features and promising biological activities, making it a subject of extensive research in recent years.

The molecular structure of (R)-tert-butyl piperidin-3-ylmethylcarbamate hydrochloride is characterized by a piperidine ring, a tertiary butyl group, and a carbamate moiety. The stereochemistry at the (R) configuration plays a crucial role in determining its pharmacokinetic properties and bioavailability. Recent studies have highlighted its potential as a precursor for the development of novel therapeutic agents, particularly in the areas of central nervous system disorders and inflammation.

One of the most notable advancements involving this compound is its application in the synthesis of bioactive molecules. Researchers have successfully utilized (R)-tert-butyl piperidin-3-ylmethylcarbamate hydrochloride as an intermediate in the construction of complex heterocyclic frameworks. These frameworks are essential for the development of drugs targeting various disease states, including cancer and neurodegenerative conditions.

In terms of pharmacological activity, (R)-tert-butyl piperidin-3-ylmethylcarbamate hydrochloride has demonstrated significant inhibitory effects on key enzymes involved in inflammatory pathways. For instance, studies have shown that this compound can modulate the activity of cyclooxygenase (COX) enzymes, which are central to inflammation and pain signaling. These findings suggest its potential as a lead compound for anti-inflammatory drug development.

Moreover, the stereochemical integrity of (R)-tert-butyl piperidin-3-ylmethylcarbamate hydrochloride has been shown to influence its pharmacokinetic profile significantly. Recent research has focused on optimizing its bioavailability through various formulation strategies, including controlled-release delivery systems. These efforts aim to enhance its therapeutic efficacy while minimizing adverse effects.

The synthesis of (R)-tert-butyl piperidin-3-ylmethylcarbamate hydrochloride involves a multi-step process that combines principles from stereochemistry and organic synthesis. The use of chiral resolving agents and asymmetric catalysis has enabled researchers to achieve high enantiomeric excess in the production process, ensuring the compound's purity and consistency.

In conclusion, (R)-tert-butyl piperidin-3-ylmethylcarbamate hydrochloride represents a promising chemical entity with diverse applications in drug discovery and development. Its unique structure, coupled with its favorable pharmacokinetic properties, positions it as a valuable tool for advancing therapeutic interventions across multiple therapeutic areas.

• 135632-53-0(tert-butyl N-(4-piperidylmethyl)carbamate)
• 879275-33-9(tert-butyl N-[[(3R)-3-piperidyl]methyl]carbamate)
• 1159826-58-0(4-(Boc-aminoethyl)piperidine Hydrochloride)
• 1185133-03-2(tert-Butyl (piperidin-4-ylmethyl)carbamate dihydrochloride)
• 1049727-98-1(tert-Butyl (piperidin-4-ylmethyl)carbamate hydrochloride)
• 1159826-67-1(tert-butyl N-(piperidin-3-ylmethyl)carbamate hydrochloride)
• 1016167-99-9(tert-butyl N-[(3S)-piperidin-3-ylmethyl]carbamate)
• 142643-29-6(tert-butyl N-(3-piperidylmethyl)carbamate)
• 215305-98-9(tert-butyl N-[2-(piperidin-3-yl)ethyl]carbamate)
• 1217805-12-3((S)-tert-Butyl (piperidin-3-ylmethyl)carbamate hydrochloride)